Nuvation Bio Inc

For the period ended Jun 30, 2024. Filed Aug 5, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2024 · Filed Aug 5, 2024

NUVB$4.16-0.7%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Signatures

Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized in the City of New York, State of New York, on this 5th day of August, 2024.

	NUVATION BIO INC.
Date: August 5, 2024	/s/ David Hung, M.D.
	David Hung, M.D.
	Founder, President and Chief Executive Officer
Date: August 5, 2024	/s/ Moses Makunje
	Moses Makunje, VP, Finance Principal Financial and Accounting Officer

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.